SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-15-000049
Filing Date
2015-08-05
Accepted
2015-08-05 16:07:15
Documents
15
Period of Report
2015-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20150805x8xkdoc.htm 8-K 33044
2 PRESS RELEASE pdli-20150805x8xkex991.htm EX-99.1 145139
3 PRESENTATION pdli-20150805x8xkex992.htm EX-99.2 4677
4 INFORMATION SHEET pdli-20150805x8xkex993.htm EX-99.3 511362
5 LOGO pdllogo75a01a02a01a01.jpg GRAPHIC 5218
6 slide1a10.jpg GRAPHIC 130186
7 slide2a10.jpg GRAPHIC 221518
8 slide3a10.jpg GRAPHIC 101005
9 slide4a10.jpg GRAPHIC 173873
10 slide5a10.jpg GRAPHIC 109923
11 slide6a10.jpg GRAPHIC 145088
12 slide7a10.jpg GRAPHIC 179846
13 slide8a10.jpg GRAPHIC 162416
14 slide9a07.jpg GRAPHIC 138267
15 slide10a06.jpg GRAPHIC 116087
  Complete submission text file 0000882104-15-000049.txt   2739661
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 151029035
SIC: 2836 Biological Products, (No Diagnostic Substances)